| Name | Title | Contact Details |
|---|
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
AZTherapies, Inc. is a private, late-stage clinical biopharmaceutical company developing treatments for devastating neurological conditions.
TAMI North America is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Stephen L. LaFrance, a certified pharmacist, founded the USA Drug family in February 1968. The retail drug store chain now boasts over 110 retail outlets in Tennessee, Mississippi, Missouri, and Arkansas, branded as USA Drug, Super D Drugs and Ike's Deep
Thornhill Research Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.